Back

Association between RNA modification N6-methyladenosine (m6A) and neurological outcome after cardiac arrest

29 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - RNA biology, epigenetic modifications, and cardiovascular risk Genetics, Epigenetics, ncRNA ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Victoria Stopa

Luxembourg Institute of Health, Strassen (Luxembourg)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor K. Kokot (Leipzig, DE)
Abstract
Presentation thumbnail
Doctor H. Li (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Ms O. Bavuu (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Mr D. Bagues Castro (Oviedo, ES)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - RNA biology, epigenetic modifications, and cardiovascular risk

The Event

Event poster

ESC Congress 2025

29 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Metabolic profiles as predictors of mortality and neurological outcomes in out-of-hospital cardiac arrest patients
thumbnail
Congress Presentation
METTL3 drives heart failure by regulating Spp1 and Fos m6A modification in myocardial infarction
thumbnail
Congress Presentation
Characterisation of plasma proteins and circulating microRNAs in out-of-hospital cardiac arrest patients - approaches for predicting outcome

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources